Loading…
Reported covered position: Legislative Director, U.S. Rep. Jim McDermott; Staff Director, U.S. Senate HELP Retirement and Aging Subcommittee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patient Safety and Toxicology Modernization Act of 2016
Client: ORGANOVO, INC. · Firm: ORGANOVO, INC.
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act Issues related to H.R. 6463 Patient Safety Toxicology Modernization Act
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ORGANOVO, INC. via ORGANOVO, INC.
2017 · third_quarter · 3T
Issues related to the reauthorization of the Prescription Drug User Fee Act. Issues related to the implementation of PL 114-255, the 21st Century Cures Act.
Issues related to the FY 18 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
Issues related to the "21st Century Cures" agenda, including: S.2689, the Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) act; and S. 185, Promise for Antibiotics and Therapeutics for Health (PATH) Act; Issues related to the FY'17 Labor, HHS and Agriculture Appropriations funding legislation
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Issues related to the "21st Century Cures" agenda, including: S.2689, the Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) act; and S. 185, Promise for Antibiotics and Therapeutics for Health (PATH) Act; Issues related to the FY'17 Labor, HHS and Agriculture Appropriations funding legislation
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act Issues related to H.R. 6463 Patient Safety Toxicology Modernization Act
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Issues related to the "21st Century Cures" agenda, including: S.2689, the Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) act; and S. 185, Promise for Antibiotics and Therapeutics for Health (PATH) Act; Issues related to the FY'17 Labor, HHS and Agriculture Appropriations funding legislation
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Issues related to the "21st Century Cures" agenda, including: S.2689, the Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) act; and S. 185, Promise for Antibiotics and Therapeutics for Health (PATH) Act; Issues related to the FY'17 Labor, HHS and Agriculture Appropriations funding legislation
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act Issues related to H.R. 6463 Patient Safety Toxicology Modernization Act
Issues related to S.679, Toxic Substances Control Act (TSCA).
Issues related to S.679, Toxic Substances Control Act (TSCA).
Issues related to S.679, Toxic Substances Control Act (TSCA).
ORGANOVO, INC. via ORGANOVO, INC.
2017 · second_quarter · Q2
Issues related to the FY 18 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts.
Issues related to the reauthorization of the Prescription Drug User Fee Act. Issues related to the implementation of PL 114-255, the 21st Century Cures Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOVO, INC. via ORGANOVO, INC.
2017 · first_quarter · 1A
Issues related to the reauthorization of the Prescription Drug User Fee Act. Issues related to the implementation of PL 114-255, the 21st Century Cures Act.
Issues related to the FY 17 and FY 18 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOVO, INC. via ORGANOVO, INC.
2017 · first_quarter · Q1
Issues related to the reauthorization of the Prescription Drug User Fee Act. Issues related to the implementation of PL 114-255, the 21st Century Cures Act.
Issues related to the FY 17 and FY 18 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOVO, INC. via ORGANOVO, INC.
2016 · fourth_quarter · Q4
Issues related to the FY'17 Labor-HHS and Agriculture Appropriations funding bills
Issues related to S.679, Toxic Substances Control Act (TSCA).
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act Issues related to H.R. 6463 Patient Safety Toxicology Modernization Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOVO, INC. via ORGANOVO, INC.
2016 · third_quarter · Q3
Issues related to the FY'17 Labor-HHS and Agriculture Appropriations funding bills
Issues related to S.679, Toxic Substances Control Act (TSCA).
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOVO, INC. via ORGANOVO, INC.
2016 · second_quarter · Q2
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Issues related to the FY'17 Labor-HHS and Agriculture Appropriations funding bills
Issues related to S.679, Toxic Substances Control Act (TSCA).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOVO, INC. via ORGANOVO, INC.
2016 · first_quarter · 1A
Issues related to S. 2689 Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act Issues related to S. 185 Promise for Antibiotics and Therapeutics for Health (PATH) Act
Issues related to the FY'17 Labor-HHS and Agriculture Appropriations funding bills
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOVO, INC. via ORGANOVO, INC.
2016 · first_quarter · RR
Issues related to the "21st Century Cures" agenda, including: S.2689, the Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) act; and S. 185, Promise for Antibiotics and Therapeutics for Health (PATH) Act; Issues related to the FY'17 Labor, HHS and Agriculture Appropriations funding legislation
Issues related to the "21st Century Cures" agenda, including: S.2689, the Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) act; and S. 185, Promise for Antibiotics and Therapeutics for Health (PATH) Act; Issues related to the FY'17 Labor, HHS and Agriculture Appropriations funding legislation